FDA requires black box warnings on labeling for botulinum toxin products. JAMA : the journal of the American Medical Association [JAMA] Journal article

Title	FDA requires black box warnings on labeling for botulinum toxin products.
Author(s)	Kuehn BM
Source	JAMA 2009 Jun 10; 301(22):2316.
MeSH	Botulinum Toxins Drug Labeling Humans Risk United States United States Food and Drug Administration
Language	eng
Pub Type(s)	News
PubMed ID	19509371

Advertise on this site.